Ligand Pharmaceuticals
LGND
LGND
233 hedge funds and large institutions have $2.51B invested in Ligand Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 86 increasing their positions, 77 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
12% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 77
3% less call options, than puts
Call options by funds: $3.65M | Put options by funds: $3.77M
Holders
233
Holding in Top 10
9
Calls
$3.65M
Puts
$3.77M
Top Buyers
| 1 | +$34.3M | |
| 2 | +$16M | |
| 3 | +$11.1M | |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$8.34M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.67M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$23M | |
| 3 | -$18.3M | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$8.07M |
| 5 |
Bank of New York Mellon
New York
|
-$7.35M |